3451 PLANO PARKWAY, LEWISVILLE, TX
Reg. FD
Shareholders Approve Amendment No. 5 to Stock Purchase Plan
Orthofix Medical Inc. Updates Financial Outlook Following FDA Device Reclassi...
Reports First Quarter 2026 Results Highlighting Steady Execution Following Spine Commercial Channel Actions; Reaffirms Full-Year 2026 Financial Guidance
Realigns Spine Leadership to Strengthen Focus and Execution
Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides 2026 Financial Guidance
Reports Third Quarter 2025 Financial Results
Reports Second Quarter 2025 Financial Results
Q1
FY 2025
Q3
Q2
FY 2024
S-3ASR
Registration Statement for Securities to be Offered to Employees
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Specialized Disclosure Report